US pharmaceutical giants trialing 'exciting' experimental melanoma drug

from 3AW Breakfast with Ross and Russel · host 3AW

Australian Personalised mRNA Cancer Immunotherapy Hub Head associate professor Seth Cheetham joined Ross Stevenson and Russel Howcroft to discuss an experimental melanoma drug that delivers treatment tailored to a patient's specific tumour which has prevented the deadly form of skin cancer from returning in a large clinical trial by US pharmaceutical giants Merck and Moderna. See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Aug 21, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

US pharmaceutical giants trialing 'exciting' experimental melanoma drug

0:00 3:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 3AW Breakfast with Ross and Russel?

This episode is 3 minutes long.

When was this 3AW Breakfast with Ross and Russel episode published?

This episode was published on August 21, 2026.

Can I download this 3AW Breakfast with Ross and Russel episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!